A retrospective, descriptive study in patients of Eosinophilic Granulomatosis with Polyangiitis (EGPA) comparing clinical characteristics and outcomes of ANCA positive EGPA patients with those of ANCA negative ones
Latest Information Update: 24 Jun 2021
At a glance
- Drugs Azathioprine (Primary) ; Cyclophosphamide (Primary) ; Mepolizumab (Primary) ; Methotrexate (Primary) ; Mycophenolate mofetil (Primary) ; Rituximab (Primary) ; Steroids
- Indications Churg-Strauss syndrome
- Focus Therapeutic Use
- 24 Jun 2021 New trial record
- 05 Jun 2021 Results presented at the 22nd Annual Congress of the European League Against Rheumatism